|
IQVIA™ Real-World Insights Bibliography
| Overview of the European post-authorisation study register post-authorization studies performed in Europe from September 2010 to December 2018 |
| Author(s): Janet Sultana 1 2, Salvatore Crisafulli 3, Mariana Almas 4, Ippazio Cosimo Antonazzo 5 6, Esme Baan 7, Claudia Bartolini 6, Maria Paola Bertuccio 3, Fedele Bonifazi 8 9, Annalisa Capuano 10 11, Antonella Didio 8 9, Vera Ehrenstein 12, Mariagrazia Felisi 8 13, Carmen Ferrajolo 10 11, Andrea Fontana 14, Remy Francisca 7, Annie Fourrier-Reglat 15, Joan Fortuny 16, Rosa Gini 6, Giulia Hyeraci 6, Christel Hoeve 7, Christos Kontogiorgis 17, Valentina Isgrò 18, Panagiotis-Nikolaos Lalagkas 17, Luca L'Abbate 18, Deborah Layton 19, Annalisa Landi 8 9, Silvia Narduzzi 19, Leonardo Roque Pereira 20, Georgios Poulentzas 17, Concetta Rafaniello 10 11, Giuseppe Roberto 6, Giulia Scondotto 3, Liberata Sportiello 10 11, Maddalena Toma 8 9, Massoud Toussi 19, Katia Verhamme 7, Elisabetta Volpe 8 9, Gianluca Trifirò 18, |
| Affiliations(s): Pharmacy Department, Mater Dei Hospital, Msida, Malta.
2Exeter College of Medicine and Health, Exeter, UK.
3Department of Medicine, University of Verona, Verona, Italy.
4Real World Solutions Department, IQVIA, Lisbon, Portugal.
5Research Centre on Public Health (CESP), University of Milan-Bicocca, Milan, Italy.
6Agenzia Regionale di Sanità della Toscana, Florence, Italy.
7Department of Medical Informatics, Erasmus Medical Centre, Rotterdam, The Netherlands.
8TEDDY European Network of Excellence for Paediatric Clinical Research, Pavia, Italy.
9Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus, Bari, Italy.
10Department of Experimental Medicine, University of Campania "Vanvitelli", Naples, Italy.
11Campania Regional Center of Pharmacovigilance and Pharmacoepidemiology, Naples, Italy.
12Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
13CVBF Consorzio per Valutazioni Biologiche e Farmacologiche, Pavia, Italy.
14Unit of Biostatistics, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
15Univ. Bordeaux, INSERM, Bordeaux Population Health Research Center, Team of Pharmacoepidemiology, UMR 1219, Bordeaux, France.
16RTI Health Solutions, Barcelona, Spain.
17Democritus University of Thrace, Alexandroupolis, Greece.
18Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
19Data Science Hub, Real World Solutions, IQVIA, London, UK.
20Department of Datascience & Biostatistics, University Medical Center Utrecht, Utrecht, The Netherlands. |
Publication(s): Pharmacoepidemiol Drug Saf
. 2022 Jun;31(6):689-705. doi: 10.1002/pds.5413. Epub 2022 Feb 11.
|
| Document Type(s): Article, |
| Countries: Denmark, France, Italy, Netherlands, Portugal, Spain, UK, |
| Click here for the abstract |
C:
Y: |
Drug safety, Drug Utlization Study,
2022 |
|
L:
A: |
English
Database Study, Review, |
|
 |
| |
| |
| Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Portugal |
| Author(s): Nuno Marques 1, Laetitia Gerlier 2, Mafalda Ramos 3, Helder Pereira 4, Sérgia Rocha 5, Ana Catarina Fonseca 6, Ana André 7, Ricardo Melo 8, Eduard Sidelnikov 9 |
| Affiliations(s): 1Department of Cardiology, Centro Hospitalar e Universitário do Algarve, Faro, Portugal.
2IQVIA, Zaventem, Belgium.
3IQVIA, Zaventem, Belgium. Electronic address: mafalda.ramos@iqvia.com.
4Department of Cardiology, Hospital Garcia de Orta, Almada, Portugal.
5Department of Cardiology, Hospital de Braga, Braga, Portugal.
6Department of Neurology, Hospital de Santa Maria, Universidade de Lisboa, Lisboa, Portugal.
7Department of Neurology, Centro Hospitalar e Universitário do Algarve, Faro, Portugal.
8Amgen SA, Portugal.
9Amgen (Europe) GmbH, Rotkreuz, Switzerland. |
Publication(s): PMID: 33581948 DOI: 10.1016/j.repc.2020.05.019
IQVIA HEOR Zaventem Brussels
Revista Portuguesa de Cardiologia Volume 40, Issue 2, February 2021, Pages 109-115.
|
| Document Type(s): Article, |
| Countries: Portugal, |
| Click here for the abstract |
C:
Y: |
Cardiovascular disease, Health economics,
2021 |
|
L:
A: |
English
Burden of illness, Clinical setting: Primary care, Prospective study, |
|
|
| |
| |
| The Burden Of Hpv In Head And Neck Cancers - Design Of The Broaden Study |
| Author(s): Gómez Ulloa D1, Morais E2, Fenoll R1, Kothari S3, Giuliano A4, Mirghani H5, Mehanna H6, Waterboer T7, Roberts C3, Varga S3, Tu Y3, Pérez G3, Saah A3, Alemany L8 |
| Affiliations(s): 1 IQVIA, Barcelona, Spain 2 MSD, CORE, Lyon, France 3 Merck & Co. Inc., Center for Observational and Real-world Evidence, Kenilworth, NJ, US 4 Moffitt Cancer Center and Research Institute, Center for Immunization and Infection Research in Cancer, Tampa, FL, US 5 HEGP, ORL, Paris, France 6 InHANSE, Head and Neck Surgery, Birmingham, UK 7 German Cancer Research Center (DKFZ), Infections and Cancer Epidemiology, Heidelberg, Germany 8 Catalan Institute of Oncology - IDIBELL, On behalf of Unit of Cancer and Infection in the Cancer Epidemiology Research Programme, Hospitalet Del Llobregat, Spain |
Publication(s): IPVC, Barcelona, Spain, 23-27 March 2020
|
| Document Type(s): Oral presentation, |
| Countries: China, France, Germany, Italy, Japan, Portugal, Spain, |
C:
Y: |
Infectious disease, Oncology,
2020 |
|
L:
A: |
English
Burden of illness, Observational study, Retrospective Field Study, |
|
|
| |
| |
| EVALUATION OF THE EFFECTIVENESS OF RISK MINIMISATION MEASURES TARGETING PHYSICIANS ON PRESCRIBING PRACTICES OF THIOCOLCHICOSIDE (TCC) CONTAINING MEDICINAL PRODUCTS FOR SYSTEMIC USE |
| Author(s): Laurence Sophie Jouaville, Carole Ehrhardt, Marie-Laure Kürzinger, Hanka de Voogd, Massoud Toussi |
| Affiliations(s): Real World Evidence Solutions, IQVIA, France;
Global Pharmacovigilance ? Global Safety Sciences - Risk Management, Sanofi;
Epidemiology and Benefit Risk Evaluation, Sanofi;
Global Clinical Sciences;
Vaccines & Anti-Infectives, Mylan, The Netherlands |
Publication(s): Poster presented at: 35th International Conference an Pharmacoepidemiology and Therapeutic Risk Management (ICPE) Pennsylvania Convention Center Philadelphia, Pennsylvania August 24-28, 2019
|
| Document Type(s): Poster, |
| Countries: France, Greece, Italy, Portugal, |
| Click here for the abstract |
C:
Y: |
Health policy, Musculoskeletal disease,
2019 |
|
L:
A: |
English
Survey research, |
|
|
| |
| |
| Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Europe |
| Author(s): Kotseva K1, Gerlier L2, Sidelnikov E3, Kutikova L3, Lamotte M2, Amarenco P4, Annemans L5 |
| Affiliations(s): 1 Department of Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, UK 2 IQVIA, Zaventem, Belgium 3 Amgen (Europe) GmbH, Rotkreuz, Switzerland 4 Department of Neurology and Stroke Centre, Bichat Hospital, Paris, France 5 University of Ghent, Belgium |
Publication(s): Eur J Prev Cardiol. 2019 Jul;26(11):1150-1157.
|
| Document Type(s): Article, |
| Countries: Belgium, France, Poland, Portugal, Spain, Switzerland, UK, |
| Click here for the abstract |
C:
Y: |
Cardiovascular disease, Health economics,
2019 |
|
L:
A: |
English
Burden of illness, Clinical setting: Primary care, direct to patient research, Observational study, |
|
|
| |
| |
| Evaluation of the Effectiveness of Risk Minimisation Measures Targeting Physicians on Prescribing Practices of Thiocolchicoside Containing Medicinal Products for Systemic Use |
| Author(s): Jouaville LS, Ehrhardt C, Kürzinger ML, de Voogd H, Toussi M |
| Affiliations(s): IQVIA |
Publication(s): Epidemiology (Sunnyvale) 9: 372. DOI: 10.4172/2161-1165.1000372
|
| Document Type(s): Article, |
| Countries: France, Greece, Italy, Portugal, |
| Click here for the abstract |
C:
Y: |
Musculoskeletal disease, Rheumatology, Risk Management & REMS,
2019 |
|
L:
A: |
English
Survey research, |
|
|
| |
| |
| Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Europe. |
| Author(s): Kotseva K1, Gerlier L2, Sidelnikov E3, Kutikova L3, Lamotte M2, Annemans L4, Amarenco P5 |
| Affiliations(s): 1 Imperial College London, London, United Kingdom 2 IQVIA, Zaventem, Belgium 3 Amgen Europe GmbH, Zug, Switzerland 4 Ghent University, Ghent, Belgium 5 Hospital Bichat-Claude Bernard, Paris, France |
Publication(s): European Society of Cardiology (ESC) Congress, 2018, Munich, Germany
|
| Document Type(s): Poster, |
| Countries: Belgium, France, Poland, Portugal, Spain, Switzerland, UK, |
| Click here for the abstract |
C:
Y: |
Cardiovascular disease, Health economics,
2018 |
|
L:
A: |
English
Burden of illness, Cost of illness, |
|
|
| |
| |
| Direct and Indirect Protection with Pediatric Quadrivalent Live-Attenuated Influenza Vaccination in Europe Estimated by a Dynamic Transmission Model |
| Author(s): Gerlier L1, Hackett J2, Lawson R2, Dos Santos Mendes S3, Weil-Olivier C4, Schwehm M5, Eichner M6,7 |
| Affiliations(s): 1 QuintilesIMS, Real-World Evidence Solutions, Zaventem, Belgium 2 AstraZeneca, Gaithersburg, MD, USA 3 AstraZeneca, Brussels, Belgium (Current affiliation: MSD, Brussels, Belgium) 4 Department of Pediatrics, University Paris VII, Paris, France 5 ExploSYS GmbH, Leinfelden-Echterdingen, Germany 6 Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany 7 Epimos GmbH, Dusslingen, Germany |
Publication(s): JHEOR 2017;5(1):89-108
|
| Document Type(s): Article, |
| Countries: Australia, Belgium, Finland, France, Germany, Greece, Italy, Luxembourg, Netherlands, Poland, Portugal, Spain, Sweden, UK, |
C:
Y: |
Immunology and Vaccination, Infectious disease, Respiratory disease,
2017 |
|
L:
A: |
English
Epidemiological study, Public Health, |
|
|
| |
| |
| Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature. |
| Author(s): Svedman FC1, Pillas D2, Taylor A2, Kaur M2, Linder R3, Hansson J1. |
| Affiliations(s): 1Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden.
2Centre for Observational Research, Amgen Ltd, Uxbridge, UK.
3IMS Health Sweden, Stockholm, Sweden.
|
Publication(s): Clinical Epidemiology
|
| Document Type(s): Article, |
| Countries: Australia, Austria, Belgium, Bulgaria, Croatia, Czech, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Israel, Italy, Netherlands, Norway, Poland, Portugal, Russian Federation, Serbia and Montenegro, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, UK, |
| Click here for the abstract |
C:
Y: |
Oncology,
2016 |
|
L:
A: |
English
Literature Review, |
|
|
| |
| |
| Rationale and design of a multi-center survey to evaluate productivity losses and indirect costs after cardiovascular events in Europe. |
| Author(s): Gerlier L1, Sidelnikov E2, Kutikova L2, Lamotte M1, Annemans L3 |
| Affiliations(s): 1 QuintilesIMS, Zaventem, Belgium 2 Amgen (Europe) GmbH, Zug, Switzerland 3 University of Ghent, Ghent, Belgium |
Publication(s): 19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria
|
| Document Type(s): Abstract, |
| Countries: Belgium, Czech, France, Germany, Hungary, Italy, Poland, Portugal, Romania, Spain, Switzerland, UK, |
C:
Y: |
Cardiovascular disease,
2016 |
|
L:
A: |
English
|
|
|
| |
| |
 1 of 3 
|
|
